Healthpeak Properties (NYSE:DOC) Updates FY 2026 Earnings Guidance

Healthpeak Properties (NYSE:DOC) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 1.710-1.750 for the period, compared to the consensus EPS estimate of 1.740. The company issued revenue guidance of -.

Healthpeak Properties Trading Up 1.5%

DOC stock traded up $0.25 during trading on Tuesday, hitting $16.54. The company had a trading volume of 7,752,037 shares, compared to its average volume of 8,978,054. The firm has a 50-day moving average price of $16.94 and a 200-day moving average price of $17.15. Healthpeak Properties has a 12 month low of $15.70 and a 12 month high of $19.68. The company has a quick ratio of 2.82, a current ratio of 2.82 and a debt-to-equity ratio of 1.21. The stock has a market cap of $11.50 billion, a price-to-earnings ratio of 165.44, a PEG ratio of 2.27 and a beta of 1.00.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.40. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, analysts predict that Healthpeak Properties will post 1.74 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be issued a $0.1017 dividend. The ex-dividend date is Monday, June 15th. This represents a c) annualized dividend and a yield of 7.4%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 1,220.00%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on DOC. Morgan Stanley dropped their price objective on Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating for the company in a report on Tuesday, April 28th. Citigroup reduced their target price on shares of Healthpeak Properties from $18.00 to $17.50 and set a “neutral” rating on the stock in a research note on Wednesday, April 1st. The Goldman Sachs Group assumed coverage on shares of Healthpeak Properties in a research report on Friday, January 9th. They set a “neutral” rating and a $17.00 price target for the company. Scotiabank raised shares of Healthpeak Properties to a “hold” rating in a research note on Thursday, April 23rd. Finally, Argus lowered shares of Healthpeak Properties from a “buy” rating to a “hold” rating in a report on Thursday, February 5th. Five analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, Healthpeak Properties presently has an average rating of “Hold” and an average target price of $18.04.

Hedge Funds Weigh In On Healthpeak Properties

Hedge funds have recently added to or reduced their stakes in the stock. Advocate Investing Services LLC acquired a new position in shares of Healthpeak Properties during the 4th quarter worth about $26,000. CYBER HORNET ETFs LLC bought a new stake in shares of Healthpeak Properties in the 2nd quarter valued at about $33,000. DV Equities LLC acquired a new stake in shares of Healthpeak Properties in the 4th quarter valued at approximately $36,000. Wiser Advisor Group LLC acquired a new stake in shares of Healthpeak Properties in the 3rd quarter valued at approximately $38,000. Finally, Los Angeles Capital Management LLC bought a new position in Healthpeak Properties during the 4th quarter worth approximately $55,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.